Treatment depends entirely on which bacterium is involved and how sick you are. A chronic Helicobacter pylori infection in the stomach lining requires a multi-drug antibiotic regimen lasting one to two weeks, while many acute infections from food-borne bacteria like Salmonella or Campylobacter clear on their own with nothing more than fluids and rest. Getting the approach right matters because the wrong treatment can sometimes cause more harm than the infection itself.
Not Every Bacterial Stomach Infection Needs Antibiotics
This is the single most important thing to understand before you do anything else. The phrase “bacterial stomach infection” covers a wide range of problems, from a chronic H. pylori colonization of the stomach lining to a bout of food poisoning from undercooked chicken. The treatment path splits sharply depending on which situation you’re in. H. pylori always requires antibiotic-based eradication therapy because it does not go away on its own and can lead to ulcers or worse over time. But for most cases of acute bacterial gastroenteritis in otherwise healthy adults and children, antibiotics are unnecessary. Rehydration is the cornerstone of treatment, and symptoms typically resolve without targeted antimicrobial therapy.1PubMed Central. Antibiotic treatment of acute gastroenteritis in children
Doctors reserve antibiotics for acute gastroenteritis cases where the patient is severely ill, immunocompromised, very young, very old, or has signs that the infection has spread beyond the gut. If you’re a generally healthy adult who picked up a stomach bug from a dodgy meal, rushing to get antibiotics is often the wrong move.
Getting the Right Diagnosis
Before any treatment can start, you need to know what you’re dealing with. For acute infections, a stool culture or stool pathogen panel can identify the specific bacterium. For H. pylori, the diagnostic picture is different because the infection lives in the stomach lining rather than passing through the intestines in an obvious way.
The urea breath test is generally considered the go-to non-invasive method for detecting H. pylori. It works because H. pylori produces an enzyme called urease that breaks down urea, and the breath test detects the byproducts. A meta-analysis found the test has pooled sensitivity around 96% and specificity around 93%, making it highly accurate for most patients.2PubMed Central. Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis Multiple guidelines recommend it as the primary choice both for initial diagnosis and for confirming that eradication therapy worked.3PubMed Central. Evaluation of urea breath test as a diagnostic tool for Helicobacter pylori infection in adult dyspeptic patients
That said, the breath test has blind spots. If you’re taking a proton pump inhibitor (like omeprazole), have recently used antibiotics, or have developed atrophic gastritis, the bacterial load in your stomach may be low enough to produce a false-negative result. The test can also give false positives when other urease-producing bacteria colonize a low-acid stomach. And critically, the breath test cannot detect atrophic gastritis itself, which means it can miss patients who are at higher risk for gastric cancer.4PubMed. GastroPanel Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review If your doctor suspects complications beyond a straightforward infection, endoscopy with biopsy gives a more complete picture.
Treating H. pylori
H. pylori is arguably the most medically significant bacterial stomach infection. It burrows into the mucus lining of the stomach, survives the acid by producing urease to raise the local pH, and in doing so actually changes the physical properties of the surrounding mucus.5PubMed Central. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity Left untreated, it can cause chronic gastritis, peptic ulcers, and increases the risk of stomach cancer. It does not resolve on its own, so eradication therapy is always the goal.
Treatment involves combining a proton pump inhibitor (to suppress stomach acid) with two or more antibiotics, taken for 10 to 14 days. The traditional approach, called standard triple therapy, pairs a proton pump inhibitor with two antibiotics such as amoxicillin and clarithromycin. But eradication rates with triple therapy have been slipping in many parts of the world, largely due to rising antibiotic resistance. A large observational study across European and Latin American countries found that standard triple therapy cleared the infection in only about 75% of patients.6PubMed Central. Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium
Quadruple therapy, which adds a fourth drug (typically bismuth subsalicylate or a second antibiotic), does better. That same study found quadruple regimens achieved eradication rates around 89 to 91%.6PubMed Central. Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium A meta-analysis focused on Asian populations similarly found quadruple therapy had roughly a 21% higher probability of successful eradication compared to triple therapy.7PubMed Central. Comparative Efficacy of Triple Versus Quadruple Therapy for the Eradication of Helicobacter pylori Infection in Asian Adults—A Systematic Review and Meta‐Analysis Many gastroenterologists now start with quadruple therapy as the first-line approach, especially in regions where clarithromycin resistance is common.
After you finish treatment, your doctor will typically retest you four to six weeks later using the breath test or a stool antigen test to confirm the infection is gone. If the first round fails, a different antibiotic combination is tried. Resistance is a growing challenge here: H. pylori can develop resistance through gene mutations, efflux pump changes, and biofilm formation, all of which make the bacteria harder to kill with each subsequent attempt.8PubMed Central. Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective
When Antibiotics Can Backfire
For certain acute infections, antibiotics don’t just fail to help — they can actively make things worse. The most striking example involves E. coli O157:H7, a strain that produces a dangerous toxin called Shiga toxin. Giving antibiotics to someone infected with this strain has been linked to a dramatically increased risk of hemolytic uremic syndrome, a potentially life-threatening complication that damages the kidneys, destroys red blood cells, and drops platelet counts. One study of children infected with E. coli O157:H7 found that antibiotic treatment was associated with a roughly 17-fold increased risk of developing hemolytic uremic syndrome, even after adjusting for how sick the children were at baseline.9PubMed Central. The Risk of the Hemolytic–Uremic Syndrome after Antibiotic Treatment of Escherichia coli O157:H7 Infections
A separate study found that bactericidal antibiotics, particularly beta-lactams like penicillins and cephalosporins, given in the first few days of illness were especially dangerous for this complication.10PubMed. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota The prevailing theory is that antibiotics break open the bacterial cells, releasing a flood of Shiga toxin at once. The overall evidence on this question has some conflicting findings, with certain studies showing no effect or even a protective role for antibiotics in Shiga toxin-producing E. coli infections.11PubMed. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview But given the severity of hemolytic uremic syndrome, most clinicians err on the side of withholding antibiotics when E. coli O157:H7 is suspected or confirmed.
This is one reason why getting a proper diagnosis matters so much. If you have bloody diarrhea and your doctor suspects a Shiga toxin-producing E. coli, the standard advice is supportive care only — fluids, monitoring kidney function, and watching closely for signs of hemolytic uremic syndrome. Jumping straight to antibiotics without knowing what bug you’re fighting can turn a self-limiting illness into something far more dangerous.
The C. difficile Risk
Even when antibiotics are the right treatment, they carry a secondary risk that anyone taking them should know about. Antibiotics don’t just kill the target pathogen; they also wipe out large swaths of your normal gut bacteria, which can create an opening for opportunistic infections. The most notorious of these is Clostridioides difficile (formerly Clostridium difficile), the most common cause of hospital-acquired and antibiotic-associated diarrhea.12PubMed Central. Clostridium difficile infection: guideline-based diagnosis and treatment
C. difficile produces toxins that damage the colon lining, causing symptoms ranging from mild diarrhea to severe, life-threatening colitis. The classic scenario is a patient who takes antibiotics for one infection and develops a C. difficile infection as a consequence. Treatment follows a somewhat ironic pattern: the first step is to stop the antibiotic that triggered the problem, and if symptoms persist or are severe, you treat C. difficile with different antibiotics — typically oral metronidazole, vancomycin, or fidaxomicin.13PubMed. Clostridium difficile infection This is why H. pylori eradication therapy, which involves high-dose broad-spectrum antibiotics, should always be supervised by a physician who can monitor for complications.
Hydration and Supportive Care
For most acute bacterial stomach and intestinal infections, the treatment that matters most isn’t an antibiotic — it’s keeping fluids and electrolytes in your body. Vomiting and diarrhea can quickly lead to dehydration, which is where the real danger lies, especially in children and older adults. Oral rehydration solutions work because glucose actively pulls sodium and water across the intestinal lining even while the gut is inflamed.14PubMed. Oral rehydration therapy: new explanations for an old remedy That mechanism is preserved even during infection, which is why the approach works so well.
Practical advice during an acute episode:
- Sip constantly: Small, frequent sips of an oral rehydration solution or a clear electrolyte drink are better tolerated than gulping large amounts at once.
- Ease back into food: Once you can keep liquids down, start with bland, easy-to-digest foods. There’s no strong evidence for the old “BRAT diet” specifically, but avoiding fatty, spicy, and dairy-heavy foods during recovery is sensible.
- Watch for warning signs: Bloody stool, high fever, inability to keep any fluids down, signs of dehydration (dark urine, dizziness, rapid heart rate), or symptoms lasting more than a few days all warrant a trip to the doctor.
For mild to moderate traveler’s diarrhea, loperamide (the active ingredient in Imodide) can help control symptoms. A systematic review found no proof that antibiotics are significantly more effective than loperamide for mild to moderate cases, and loperamide has the advantage of not contributing to antibiotic resistance.15Food Control. Systematic review of loperamide: No proof of antibiotics being superior to loperamide in treatment of mild/moderate travellers’ diarrhoea Loperamide should be avoided, however, if you have a high fever or bloody stools, as slowing gut motility in the setting of an invasive infection can worsen outcomes.
Probiotics as an Add-On
Probiotics have attracted significant interest as a way to support recovery and reduce the side effects of antibiotic treatment. The most studied strain in this context is Saccharomyces boulardii, a non-pathogenic yeast. Clinical trials have shown it to be effective in preventing and treating antibiotic-associated diarrhea and infectious diarrhea.16PubMed Central. Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption Multiple trials and experimental studies support its role as a complementary therapy for various gastrointestinal disorders.17PubMed Central. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders
If you’re undergoing H. pylori eradication therapy, taking S. boulardii alongside your antibiotics may help reduce treatment-related diarrhea and improve your ability to complete the full course. It’s worth noting that S. boulardii is a yeast, not a bacterium, so it isn’t killed by the antibiotics you’re taking — a practical advantage over bacterial probiotic strains. Probiotics aren’t a standalone cure for any bacterial stomach infection, but they have a reasonable evidence base as an adjunct, and the risk of side effects is low for most people. Immunocompromised patients should check with their doctor before taking any probiotic, including S. boulardii.
When the Infection Leaves Lasting Effects
Even after a bacterial stomach infection resolves, some people develop chronic digestive symptoms that persist for months or years. This condition is known as post-infectious irritable bowel syndrome, and published studies report it develops in somewhere between 5% and 32% of people after an episode of acute gastroenteritis.18PubMed Central. Post-infectious irritable bowel syndrome A meta-analysis found that people who had a gut infection were about six times more likely to develop IBS than those who hadn’t, and this elevated risk persisted for at least two to three years after the original infection.19PubMed. Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome
Bacterial and protozoal infections appear to carry a higher risk of triggering post-infectious IBS than viral ones. Younger people, women, and those who had a particularly severe initial illness seem to be more vulnerable.20PubMed Central. Post-infection Irritable Bowel Syndrome The mechanisms behind it aren’t fully mapped out, but they appear to involve lingering low-grade inflammation, disrupted gut bacteria, changes in intestinal permeability, and remodeling of the gut’s nerve and immune systems. If you’ve recovered from a bacterial stomach infection but still have cramping, bloating, or erratic bowel habits months later, it’s worth bringing up with your doctor rather than assuming something is still infected.
Campylobacter infections carry an additional rare but serious risk. About a quarter of Guillain-Barré syndrome cases have been linked to prior Campylobacter jejuni infection.21PubMed. Campylobacter jejuni infection and Guillain-Barré syndrome The bacterium carries surface structures that resemble components of human nerve tissue, and the immune response against the bacterium can accidentally attack the peripheral nerves through a process called molecular mimicry.22PubMed Central. Campylobacter species and Guillain-Barré syndrome Guillain-Barré syndrome causes muscle weakness that can progress to paralysis; it’s rare overall, but Campylobacter is one of its most identified triggers. Symptoms typically appear one to three weeks after the gut infection and require prompt medical attention.
How Bacteria Get In and How to Reduce Your Risk
Campylobacter is a good example of how sophisticated these bacteria can be as pathogens. It uses chemically guided motility to navigate through thick intestinal mucus, then deploys adhesion proteins to latch onto intestinal cells. Once attached, it can open the junctions between cells, slip through, and invade the tissue underneath. It produces a toxin that pushes host cells into programmed death, which releases inflammatory signals and causes the tissue damage you experience as symptoms.23PubMed Central. Campylobacter jejuni: targeting host cells, adhesion, invasion, and survival Understanding this helps explain why a healthy immune system sometimes isn’t enough on its own — the bacteria have evolved very specific mechanisms to penetrate your defenses.
Prevention, then, is genuinely the best medicine. The majority of acute bacterial stomach infections come from contaminated food, water, or contact with contaminated surfaces. Handwashing before and during food preparation is consistently identified as the single most important hygiene measure in the home kitchen.24Food Control. Hygiene in the home kitchen: Changes in behaviour and impact of key microbiological hazard control measures Beyond handwashing, research on home kitchen hygiene shows that standard cleaning methods produce modest reductions in surface contamination, but adding a drying or disinfection step roughly doubles the effectiveness.25Journal of Applied Microbiology. The effects of different hygiene procedures in reducing bacterial contamination in a model domestic kitchen Cooking meat to proper internal temperatures, avoiding cross-contamination between raw meat and ready-to-eat foods, and refrigerating leftovers promptly are all straightforward steps that make a real difference.
For travelers, the classic advice still holds: be cautious with tap water, ice, raw produce, and street food in regions with less reliable sanitation infrastructure. H. pylori transmission is less about food safety and more about close person-to-person contact, typically acquired in childhood. You’re unlikely to “catch” H. pylori from a restaurant meal the way you might pick up Salmonella.
Why Your Genetics Might Matter
Not everyone who encounters a bacterial pathogen gets equally sick, and part of the explanation is genetic. Research has identified a gene called FUT2, which determines whether you are a “secretor” — meaning you express certain sugar molecules on the surface of your intestinal cells and in your body fluids. A study in Bangladesh found that people with specific non-secretor variants of FUT2 were significantly more susceptible to symptomatic infection from enterotoxigenic E. coli, a major cause of traveler’s diarrhea.26Scientific Reports. FUT2 non-secretor status is associated with altered susceptibility to symptomatic enterotoxigenic Escherichia coli infection in Bangladeshis Secretor status has also been linked to susceptibility to norovirus and other gut pathogens, though the direction of the effect varies by pathogen.
You can’t change your genetics, but this research helps explain a common frustration: why two people eat the same meal and only one gets sick. It’s not always about the dose of bacteria; individual biology plays a genuine role. This kind of work also informs vaccine development. Vaccines that target enterotoxigenic E. coli, for instance, may need to account for the fact that the bacteria interact differently with the intestinal lining depending on the host’s secretor status.
Phage Therapy and the Future of Treatment
With antibiotic resistance on the rise across many gut pathogens, researchers are looking beyond conventional drugs. One of the more promising areas is phage therapy, which uses bacteriophages — viruses that specifically infect and kill bacteria — as therapeutic agents. Current research suggests phage therapy could work as either an alternative or a supplement to antibiotics, particularly for multidrug-resistant infections.27PubMed Central. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Phages have a key advantage over antibiotics: they tend to be highly specific, targeting one species or even one strain while leaving the rest of the gut microbiome intact. That specificity would, in theory, drastically reduce the risk of collateral damage like C. difficile infection. The drawbacks are that specificity also makes treatment harder to standardize — you need to match the right phage to the right pathogen — and regulatory frameworks for phage therapy are still underdeveloped in most countries. Phage therapy is currently used in clinical practice in a few countries, notably Georgia, and compassionate-use cases have been reported elsewhere, but widespread clinical adoption is still years away. For now, antibiotics remain the mainstay, and the most practical thing you can do about resistance is to only use them when they’re genuinely needed.